Michael D. Capellas - 14 May 2021 Form 4 Insider Report for Beauty Health Co (SKIN)

Reporting relationship: Director
Issuer ticker: SKIN
Reported as of: 14 May 2021
Net transaction value: +$350,000
SEC form: 4
Accepted by SEC: 18 Aug 2023, 12:42:23 UTC
Next SEC filing: 28 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Michael D. Capellas

Key filing fact

Michael D. Capellas filed Form 4 for Beauty Health Co (SKIN) on 18 Aug 2023.

Key facts

This page summarizes Michael D. Capellas's Form 4 filing for Beauty Health Co (SKIN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Aug 2023, 12:42.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$350,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SKIN transaction

Class A Common Stock

Other

Transaction value
Shares: +136,162
Change %: +433%
Price
Shares after: 167,612
Date: 14 May 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SKIN transaction Derivative

Warrant (right to buy)

Other

Transaction value: $350,000
Shares: +233,333
Change %
Price: $1.50^*
Shares after: 233,333
Date: 14 May 2021
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 233,333
Exercise price: $11.50
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported securities were received in a distribution by BLS Investor Group LLC ("BLS") in accordance with the reporting person's membership interest in BLS, as reported in the issuer's Form S-1 filed with the Securities and Exchange Commission on July 19, 2021.

Footnote F2

The warrants are exercisable by the holder into shares of Class A Common Stock on a one-for-one basis commencing on 10/2/2021, and expire on 5/4/2026 or earlier redemption or liquidation.